The National Testing Agency released the provisional answer key for the NIFT Entrance Exam 2025; candidates can challenge it until February 17. Despite the release, technical issues with the ...
NIFT Entrance Exam 2025: Candidates can challenge any answer by paying a fee of Rs 200 per question. NIFT Entrance Exam 2025 Answer Key: The National Testing Agency (NTA) has released the ...
If any of these are confirmed to be true, a final answer key will be provided, from which the NIFT result 2025 will be released. “The provisional answer keys of shift 1 (general ability test ...
Mumbai: In this financial year, the paediatric cancer dept of the centre-run Tata Memorial Centre raised around Rs 60 crore to ensure free treatment for the majority of 4,000-odd children with ...
Tata Nexon price in Navi Mumbai start at ₹ 8.15 Lakh. The lowest price model is Tata Nexon Smart and the top model price is Tata Nexon Fearless Plus PS Dark Diesel AMT priced at ₹ 15.60 Lakh.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Twice a year for the past decade, Vusumzi Nguse has walked down the potholed streets of his township to the ...
Tata Nexon Smart Plus S Rs. 10.22 Lakh * Tata Nexon Smart Plus AMT Rs. 10.66 Lakh * Tata Nexon Pure Plus Rs. 10.77 Lakh * Tata Nexon Smart Plus Diesel Rs. 11.10 Lakh * Tata Nexon Pure Plus S Rs ...
Wrong twice!! I took it to AutoSmith and within a day, they had it figured out. Mills Ford, you are NOT knowledgeable, way overpriced and should be ashamed of your policies. I will NEVER go back ...
The recorded responses of NIFT 2025 have also been released along with the answer key. The exam was held on February 9, 2025. Candidates who appeared in the exam can check the answer key, question ...
Plus, insights on IREDA and Tata Technologies' new trading contracts, Cyient's executive appointment, Patanjali Foods' legal victory, and Orchid Pharma's recent FDA inspection. Stay informed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results